Backlinks
| Referring page | DR | Ref. domains | Linked domains | Anchor and target URL |
|---|---|---|---|---|
|
Podcasts - PharmaLex
https://www.pharmalex.com/thought-leadership/podcasts
pharmalex.com
|
65 | 19 | 105 |
SIGN UP NOW
https://go.cencora.com/l/168232/2024-01-08/5l2pf1
DOFOLLOW
|
|
Combination products and the FDA - PharmaLex
https://www.pharmalex.com/thought-leadership/blogs/combination-products-and-the-fda
pharmalex.com
|
65 | 19 | 105 |
SIGN UP NOW
https://go.cencora.com/l/168232/2024-01-08/5l2pf1
DOFOLLOW
|
|
Safety Reporting Requirements for Marketing in the EU - PharmaLex
https://www.pharmalex.com/thought-leadership/podcasts/safety-reporting-requirements-for-marketing-in-the-eu
pharmalex.com
|
65 | 19 | 105 |
SIGN UP NOW
https://go.cencora.com/l/168232/2024-01-08/5l2pf1
DOFOLLOW
|
|
Finding the best approach to manage sterility assurance - PharmaLex
https://www.pharmalex.com/thought-leadership/podcasts/finding-the-best-approach-to-manage-sterility-assurance
pharmalex.com
|
65 | 19 | 105 |
SIGN UP NOW
https://go.cencora.com/l/168232/2024-01-08/5l2pf1
DOFOLLOW
|
|
Challenges & Regulatory landscape for ATMPs - PharmaLex
https://www.pharmalex.com/thought-leadership/podcasts/challenges-regulatory-landscape-for-atmps
pharmalex.com
|
65 | 19 | 105 |
SIGN UP NOW
https://go.cencora.com/l/168232/2024-01-08/5l2pf1
DOFOLLOW
|
|
Webinars related to Regulatory Affairs and CMC - PharmaLex
https://www.pharmalex.com/pharmalex-insights/webinars/department/regulatory-affairs-and-cmc/page/4
pharmalex.com
|
65 | 19 | 105 |
<img loading="lazy" width="468" height="293" src="https://www.pharmalex.com/wp-content/uploads/2024/06/Ask-the-Experts-Unlock-the-Secrets-of-Managing-CTR-in-a-Complex-Development-Landscape-468x293.png.webp" class="attachment-news size-news wp-image-6453" alt="" srcset="https://www.pharmalex.com/wp-content/uploads/2024/06/Ask-the-Experts-Unlock-the-Secrets-of-Managing-CTR-in-a-Complex-Development-Landscape-468x293.png.webp 468w,https://www.pharmalex.com/wp-content/uploads/2024/06/Ask-the-Experts-Unlock-the-S
https://go.cencora.com/Secrets-of-Managing-CTR
NOFOLLOW
|
|
Webinars related to Regulatory Affairs and CMC - PharmaLex
https://www.pharmalex.com/pharmalex-insights/webinars/department/regulatory-affairs-and-cmc/page/4
pharmalex.com
|
65 | 19 | 105 |
Webinar Know your market<img loading="lazy" width="468" height="293" src="https://www.pharmalex.com/wp-content/uploads/2024/03/Webinar_Know-your-market-468x293.png.webp" class="attachment-news size-news wp-image-6092" alt="Webinar Know your market" srcset="https://www.pharmalex.com/wp-content/uploads/2024/03/Webinar_Know-your-market-468x293.png.webp 468w,https://www.pharmalex.com/wp-content/uploads/2024/03/Webinar_Know-your-market-265x166.png.webp 265w" sizes="(max-width: 468px) 100vw, 468px" />
https://go.cencora.com/know_your_market_combination_products
NOFOLLOW
|
|
Webinars related to Regulatory Affairs and CMC - PharmaLex
https://www.pharmalex.com/pharmalex-insights/webinars/department/regulatory-affairs-and-cmc/page/4
pharmalex.com
|
65 | 19 | 105 |
(no anchor)
https://go.cencora.com/Data_Governance_AI_in_Pharma
NOFOLLOW
|
|
Webinars related to Regulatory Affairs and CMC - PharmaLex
https://www.pharmalex.com/pharmalex-insights/webinars/department/regulatory-affairs-and-cmc/page/4
pharmalex.com
|
65 | 19 | 105 |
(no anchor)
https://go.cencora.com/Alternative_Submission_Pathways_2024
NOFOLLOW
|
|
Webinars related to Regulatory Affairs and CMC - PharmaLex
https://www.pharmalex.com/pharmalex-insights/webinars/department/regulatory-affairs-and-cmc/page/4
pharmalex.com
|
65 | 19 | 105 |
<img loading="lazy" width="468" height="293" src="https://www.pharmalex.com/wp-content/uploads/2024/07/Document-Processing_-A-New-Hope_Web-468x293.png.webp" class="attachment-news size-news wp-image-6523" alt="" srcset="https://www.pharmalex.com/wp-content/uploads/2024/07/Document-Processing_-A-New-Hope_Web-468x293.png.webp 468w,https://www.pharmalex.com/wp-content/uploads/2024/07/Document-Processing_-A-New-Hope_Web-265x166.png.webp 265w" sizes="(max-width: 468px) 100vw, 468px" />
https://go.cencora.com/Summer_shorts_document_processing
NOFOLLOW
|
|
Webinars related to Regulatory Affairs and CMC - PharmaLex
https://www.pharmalex.com/pharmalex-insights/webinars/department/regulatory-affairs-and-cmc/page/4
pharmalex.com
|
65 | 19 | 105 |
(no anchor)
https://go.cencora.com/ondemand_webinar_Unlocking-continued-revenue-and-growth-from-established-products
NOFOLLOW
|
|
Webinars related to Regulatory Affairs and CMC - PharmaLex
https://www.pharmalex.com/pharmalex-insights/webinars/department/regulatory-affairs-and-cmc/page/4
pharmalex.com
|
65 | 19 | 105 |
Webinar An AI Action Plan for the TMF Professional<img loading="lazy" width="468" height="293" src="https://www.pharmalex.com/wp-content/uploads/2024/04/Webinar-An-AI-Action-Plan-for-the-TMF-Professional-468x293.png.webp" class="attachment-news size-news wp-image-6172" alt="Webinar An AI Action Plan for the TMF Professional" srcset="https://www.pharmalex.com/wp-content/uploads/2024/04/Webinar-An-AI-Action-Plan-for-the-TMF-Professional-468x293.png.webp 468w,https://www.pharmalex.com/wp-content/uploads/2024/0
https://go.cencora.com/ai_actionplan
NOFOLLOW
|
|
Webinars related to Regulatory Affairs and CMC - PharmaLex
https://www.pharmalex.com/pharmalex-insights/webinars/department/regulatory-affairs-and-cmc/page/4
pharmalex.com
|
65 | 19 | 105 |
(no anchor)
https://go.cencora.com/House_of_the_inspector
NOFOLLOW
|
|
Webinars related to Regulatory Affairs and CMC - PharmaLex
https://www.pharmalex.com/pharmalex-insights/webinars/department/regulatory-affairs-and-cmc/page/4
pharmalex.com
|
65 | 19 | 105 |
<img loading="lazy" width="468" height="293" src="https://www.pharmalex.com/wp-content/uploads/2024/07/Risk-Based-Quality-Review_-Inside-Out_Web-468x293.png.webp" class="attachment-news size-news wp-image-6525" alt="" srcset="https://www.pharmalex.com/wp-content/uploads/2024/07/Risk-Based-Quality-Review_-Inside-Out_Web-468x293.png.webp 468w,https://www.pharmalex.com/wp-content/uploads/2024/07/Risk-Based-Quality-Review_-Inside-Out_Web-265x166.png.webp 265w" sizes="(max-width: 468px) 100vw, 468px" />
https://go.cencora.com/Risk-Based_Quality_Review_Inside_Out
NOFOLLOW
|
|
Webinars related to Regulatory Affairs and CMC - PharmaLex
https://www.pharmalex.com/pharmalex-insights/webinars/department/regulatory-affairs-and-cmc/page/4
pharmalex.com
|
65 | 19 | 105 |
<img loading="lazy" width="468" height="293" src="https://www.pharmalex.com/wp-content/uploads/2024/04/Game-On-Strategies-for-Conquering-the-Final-Boss-TMF-Close-Out-Webinar-1-468x293.png.webp" class="attachment-news size-news wp-image-6196" alt="" srcset="https://www.pharmalex.com/wp-content/uploads/2024/04/Game-On-Strategies-for-Conquering-the-Final-Boss-TMF-Close-Out-Webinar-1-468x293.png.webp 468w,https://www.pharmalex.com/wp-content/uploads/2024/04/Game-On-Strategies-for-Conquering-the-Final-Boss-TMF-C
https://go.cencora.com/game-on-2024
NOFOLLOW
|
|
Webinars related to Regulatory Affairs and CMC - PharmaLex
https://www.pharmalex.com/pharmalex-insights/webinars/department/regulatory-affairs-and-cmc/page/4
pharmalex.com
|
65 | 19 | 105 |
SIGN UP NOW
https://go.cencora.com/l/168232/2024-01-08/5l2pf1
DOFOLLOW
|
|
Improving efficiency and mitigating risk through strategic product developmen...
https://www.pharmalex.com/thought-leadership/podcasts/improving-efficiency-and-mitigating-risk-through-strategic-product-development
pharmalex.com
|
65 | 19 | 105 |
SIGN UP NOW
https://go.cencora.com/l/168232/2024-01-08/5l2pf1
DOFOLLOW
|
|
Digital Innovation - PharmaLex
pharmalex.com
|
65 | 19 | 105 |
SIGN UP NOW
https://go.cencora.com/l/168232/2024-01-08/5l2pf1
DOFOLLOW
|
|
El desafío de cumplir con las normativas en materiales promocionales de medic...
pharmalex.com
|
65 | 19 | 105 |
SIGN UP NOW
https://go.cencora.com/l/168232/2024-01-08/5l2pf1
DOFOLLOW
|
|
What’s happening with eCTD 4.0: New and future developments - PharmaLex
https://www.pharmalex.com/thought-leadership/podcasts/whats-happening-with-ectd-4-0-new-and-future-developments
pharmalex.com
|
65 | 19 | 105 |
SIGN UP NOW
https://go.cencora.com/l/168232/2024-01-08/5l2pf1
DOFOLLOW
|
|
MedTech - PharmaLex
https://www.pharmalex.com/pharmalex-industry-sectors/medtech
pharmalex.com
|
65 | 19 | 105 |
White Papers<img loading="lazy" width="468" height="293" src="https://www.pharmalex.com/wp-content/uploads/2022/10/White-Papers-Default-Featured-Image-468x293.jpg.webp" class="attachment-news size-news wp-post-image" alt="White Papers" decoding="async" srcset="https://www.pharmalex.com/wp-content/uploads/2022/10/White-Papers-Default-Featured-Image-468x293.jpg.webp 468w,https://www.pharmalex.com/wp-content/uploads/2022/10/White-Papers-Default-Featured-Image-300x188.jpg.webp 300w,https://www.pharmalex.com/wp-
https://go.cencora.com/l/168232/2023-11-22/5kxpcg
NOFOLLOW
|
|
MedTech - PharmaLex
https://www.pharmalex.com/pharmalex-industry-sectors/medtech
pharmalex.com
|
65 | 19 | 105 |
Webinar Know your market<img fetchpriority="high" fetchpriority="high" width="468" height="293" src="https://www.pharmalex.com/wp-content/uploads/2024/03/Webinar_Know-your-market-468x293.png.webp" class="attachment-news size-news wp-post-image" alt="Webinar Know your market" decoding="async" srcset="https://www.pharmalex.com/wp-content/uploads/2024/03/Webinar_Know-your-market-468x293.png.webp 468w,https://www.pharmalex.com/wp-content/uploads/2024/03/Webinar_Know-your-market-265x166.png.webp 265w" sizes="(ma
https://go.cencora.com/know_your_market_combination_products
NOFOLLOW
|
|
MedTech - PharmaLex
https://www.pharmalex.com/pharmalex-industry-sectors/medtech
pharmalex.com
|
65 | 19 | 105 |
<img loading="lazy" loading="lazy" decoding="async" width="600" height="150" src="https://www.pharmalex.com/wp-content/uploads/2022/06/Email-banner-MedTech.png.webp" class="attachment-large size-large wp-image-5819" alt="" srcset="https://www.pharmalex.com/wp-content/uploads/2022/06/Email-banner-MedTech.png.webp 600w,https://www.pharmalex.com/wp-content/uploads/2022/06/Email-banner-MedTech-300x75.png.webp 300w" sizes="(max-width: 600px) 100vw, 600px" />
https://go.cencora.com/mds_newsletter
DOFOLLOW
|
|
MedTech - PharmaLex
https://www.pharmalex.com/pharmalex-industry-sectors/medtech
pharmalex.com
|
65 | 19 | 105 |
SIGN UP NOW
https://go.cencora.com/l/168232/2024-01-08/5l2pf1
DOFOLLOW
|
|
How Bayesian thinking addresses complex issues with clinical studies - PharmaLex
https://www.pharmalex.com/thought-leadership/podcasts/how-bayesian-thinking-addresses-complex-issues-with-clinical-studies
pharmalex.com
|
65 | 19 | 105 |
SIGN UP NOW
https://go.cencora.com/l/168232/2024-01-08/5l2pf1
DOFOLLOW
|
|
Notified Body Updates for MDD, MDRs, IVDD and IVDR - PharmaLex
https://www.pharmalex.com/thought-leadership/blogs/notified-body-updates-for-mdd-mdrs-ivdd-and-ivdr
pharmalex.com
|
65 | 19 | 105 |
SIGN UP NOW
https://go.cencora.com/l/168232/2024-01-08/5l2pf1
DOFOLLOW
|
|
Environment and Climate Change Policy - PharmaLex
https://www.pharmalex.com/thought-leadership/csr-document/environment-and-climate-change-policy
pharmalex.com
|
65 | 19 | 105 |
SIGN UP NOW
https://go.cencora.com/l/168232/2024-01-08/5l2pf1
DOFOLLOW
|
|
Managing the medical device pre-submission process with the FDA - PharmaLex
https://www.pharmalex.com/thought-leadership/podcasts/managing-the-medical-device-pre-submission-process-with-the-fda
pharmalex.com
|
65 | 19 | 105 |
SIGN UP NOW
https://go.cencora.com/l/168232/2024-01-08/5l2pf1
DOFOLLOW
|
|
The bio pharmacy: market authorisations for protein-based medicines - PharmaLex
https://www.pharmalex.com/thought-leadership/blogs/the-bio-pharmacy-market-authorisations-for-protein-based-medicines
pharmalex.com
|
65 | 19 | 105 |
SIGN UP NOW
https://go.cencora.com/l/168232/2024-01-08/5l2pf1
DOFOLLOW
|
|
Strategic planning for CTR transition
https://www.pharmalex.com/thought-leadership/blogs/ctr-in-focus-strategic-planning-to-transition-to-the-eu-clinical-trials-regulation
pharmalex.com
|
65 | 19 | 105 |
SIGN UP NOW
https://go.cencora.com/l/168232/2024-01-08/5l2pf1
DOFOLLOW
|
|
White Papers related to CMC Statistics - PharmaLex
https://www.pharmalex.com/thought-leadership/white-papers/service/cmc-statistics
pharmalex.com
|
65 | 19 | 105 |
Optimal Validation Design
https://go.cencora.com/l/168232/2023-11-16/5kx3xy
NOFOLLOW
|
|
White Papers related to CMC Statistics - PharmaLex
https://www.pharmalex.com/thought-leadership/white-papers/service/cmc-statistics
pharmalex.com
|
65 | 19 | 105 |
SIGN UP NOW
https://go.cencora.com/l/168232/2024-01-08/5l2pf1
DOFOLLOW
|
|
From Molecule to Market: Navigating the Complexities of Drug Development - BI...
https://www.biodeutschland.org/de/veranstaltungen/from-molecule-to-market-navigating-the-complexities-of-drug-development.html?month=202404
biodeutschland.org
|
72 | 49 | 381 |
https://go.cencora.com/molecule-to-market-2024
https://go.cencora.com/molecule-to-market-2024
DOFOLLOW
|
|
Handling medical information in local languages
https://www.pharmalex.com/thought-leadership/blogs/why-local-language-matters-with-medical-information-inquiries
pharmalex.com
|
65 | 19 | 105 |
SIGN UP NOW
https://go.cencora.com/l/168232/2024-01-08/5l2pf1
DOFOLLOW
|
|
RAPS Convergence 2025: Transparency, Trust, and Resilience in Regulatory Scie...
https://www.pharmalex.com/thought-leadership/blogs/raps-convergence-2025-transparency-trust-and-resilience-in-regulatory-science
pharmalex.com
|
65 | 19 | 105 |
SIGN UP NOW
https://go.cencora.com/l/168232/2024-01-08/5l2pf1
DOFOLLOW
|
|
Webinars related to Optimal Patient Access - PharmaLex
https://www.pharmalex.com/pharmalex-insights/webinars/solution/optimal-patient-access
pharmalex.com
|
65 | 19 | 105 |
Toxicological Webinar
https://go.cencora.com/l/168232/2024-02-05/5l4km9
NOFOLLOW
|
|
Webinars related to Optimal Patient Access - PharmaLex
https://www.pharmalex.com/pharmalex-insights/webinars/solution/optimal-patient-access
pharmalex.com
|
65 | 19 | 105 |
Webinar
https://go.cencora.com/l/168232/2023-12-06/5kz3c8
NOFOLLOW
|
|
Webinars related to Optimal Patient Access - PharmaLex
https://www.pharmalex.com/pharmalex-insights/webinars/solution/optimal-patient-access
pharmalex.com
|
65 | 19 | 105 |
SIGN UP NOW
https://go.cencora.com/l/168232/2024-01-08/5l2pf1
DOFOLLOW
|
|
Webinars related to Optimal Patient Access - PharmaLex
https://www.pharmalex.com/pharmalex-insights/webinars/solution/optimal-patient-access
pharmalex.com
|
65 | 19 | 105 |
The Intersection Between IDMP Ontology and Good Data Governance
https://go.cencora.com/l/168232/2024-01-31/5l49dq
NOFOLLOW
|
|
Webinars related to Optimal Patient Access - PharmaLex
https://www.pharmalex.com/pharmalex-insights/webinars/solution/optimal-patient-access
pharmalex.com
|
65 | 19 | 105 |
(no anchor)
https://go.cencora.com/l/168232/2024-02-06/5l4m56
NOFOLLOW
|
|
Achieving success with radioligand therapies
https://www.pharmalex.com/thought-leadership/blogs/navigating-the-complex-field-of-radioligand-therapy-three-key-takeaways
pharmalex.com
|
65 | 19 | 105 |
SIGN UP NOW
https://go.cencora.com/l/168232/2024-01-08/5l2pf1
DOFOLLOW
|
|
Podcasts related to Optimal Patient Access - PharmaLex
https://www.pharmalex.com/thought-leadership/podcasts/solution/optimal-patient-access
pharmalex.com
|
65 | 19 | 105 |
SIGN UP NOW
https://go.cencora.com/l/168232/2024-01-08/5l2pf1
DOFOLLOW
|
|
NLS Days 2025 - PharmaLex
https://www.pharmalex.com/pharmalex-insights/events/nls-days-2025
pharmalex.com
|
65 | 19 | 105 |
<img width="468" height="293" src="https://www.pharmalex.com/wp-content/uploads/2025/08/Brain-Breakfast-Denmark-website-1-468x293.png.webp" class="attachment-news size-news wp-image-7306" alt="" srcset="https://www.pharmalex.com/wp-content/uploads/2025/08/Brain-Breakfast-Denmark-website-1-468x293.png.webp 468w,https://www.pharmalex.com/wp-content/uploads/2025/08/Brain-Breakfast-Denmark-website-1-300x188.png.webp 300w,https://www.pharmalex.com/wp-content/uploads/2025/08/Brain-Breakfast-Denmark-website-1-1024
https://go.cencora.com/Navigating_EU_HTA_BrainandBreakfast_Denmark_October-2
NOFOLLOW
|
|
NLS Days 2025 - PharmaLex
https://www.pharmalex.com/pharmalex-insights/events/nls-days-2025
pharmalex.com
|
65 | 19 | 105 |
<img width="468" height="293" src="https://www.pharmalex.com/wp-content/uploads/2025/10/Brain-Breakfast-Sweden-website-468x293.png.webp" class="attachment-news size-news wp-image-7333" alt="" srcset="https://www.pharmalex.com/wp-content/uploads/2025/10/Brain-Breakfast-Sweden-website-468x293.png.webp 468w,https://www.pharmalex.com/wp-content/uploads/2025/10/Brain-Breakfast-Sweden-website-300x188.png.webp 300w,https://www.pharmalex.com/wp-content/uploads/2025/10/Brain-Breakfast-Sweden-website-1024x640.png.web
https://go.cencora.com/Brain-and-Breakfast-Regulatory-digital-initiatives-in-the-EU
NOFOLLOW
|
|
NLS Days 2025 - PharmaLex
https://www.pharmalex.com/pharmalex-insights/events/nls-days-2025
pharmalex.com
|
65 | 19 | 105 |
SIGN UP NOW
https://go.cencora.com/l/168232/2024-01-08/5l2pf1
DOFOLLOW
|
|
Podcasts related to CMC Statistics - PharmaLex
https://www.pharmalex.com/thought-leadership/podcasts/service/cmc-statistics
pharmalex.com
|
65 | 19 | 105 |
SIGN UP NOW
https://go.cencora.com/l/168232/2024-01-08/5l2pf1
DOFOLLOW
|
|
PDA Sterilisation & Decontamination - PharmaLex
https://www.pharmalex.com/pharmalex-insights/events/pda-sterilisation-decontamination
pharmalex.com
|
65 | 19 | 105 |
SIGN UP NOW
https://go.cencora.com/l/168232/2024-01-08/5l2pf1
DOFOLLOW
|
|
Easing the Pathway for Combination Products: An Australian Regulatory Perspec...
https://www.pharmalex.com/thought-leadership/journal-articles/easing-the-pathway-for-combination-products-an-australian-regulatory-perspective
pharmalex.com
|
65 | 19 | 105 |
SIGN UP NOW
https://go.cencora.com/l/168232/2024-01-08/5l2pf1
DOFOLLOW
|
|
Sterility Testing in Bioproduction and Cell and Gene Therapy Manufacturing - ...
https://www.pharmalex.com/pharmalex-insights/events/sterility-testing-in-bioproduction-and-cell-and-gene-therapy-manufacturing
pharmalex.com
|
65 | 19 | 105 |
<img width="468" height="293" src="https://www.pharmalex.com/wp-content/uploads/2025/05/Brain-Breakfast-Finland-website-468x293.png.webp" class="attachment-news size-news wp-image-7197" alt="" srcset="https://www.pharmalex.com/wp-content/uploads/2025/05/Brain-Breakfast-Finland-website-468x293.png.webp 468w,https://www.pharmalex.com/wp-content/uploads/2025/05/Brain-Breakfast-Finland-website-300x188.png.webp 300w,https://www.pharmalex.com/wp-content/uploads/2025/05/Brain-Breakfast-Finland-website-1024x640.png
https://go.cencora.com/brain_and_breakfast_sept10_2025
NOFOLLOW
|
|
Sterility Testing in Bioproduction and Cell and Gene Therapy Manufacturing - ...
https://www.pharmalex.com/pharmalex-insights/events/sterility-testing-in-bioproduction-and-cell-and-gene-therapy-manufacturing
pharmalex.com
|
65 | 19 | 105 |
SIGN UP NOW
https://go.cencora.com/l/168232/2024-01-08/5l2pf1
DOFOLLOW
|
Frequently Asked Questions
How many backlinks does go.cencora.com have?
The backlinks page for go.cencora.com shows all individual inbound links discovered in our crawl of the web. Each backlink represents a hyperlink on another website that points to a page on go.cencora.com. Use the filters to narrow results by dofollow/nofollow status, domain rating, or anchor text.
What is a backlink?
A backlink is a hyperlink on one website that points to a page on a different website. Backlinks are one of the most important ranking factors in search engine algorithms because they act as votes of confidence from other sites. The more high-quality backlinks a domain has, the more authority search engines assign to it.
Are the backlinks to go.cencora.com dofollow or nofollow?
Backlinks to go.cencora.com include both dofollow and nofollow links. Dofollow links pass link equity (ranking power) to the target site, while nofollow links include a rel="nofollow" attribute that tells search engines not to pass authority. Both types contribute to a natural backlink profile, but dofollow links carry more SEO weight. You can filter by link type using the rel filter above the table.
How often is backlink data updated?
Backlink data is updated monthly when our web crawler completes a new cycle. Our pipeline processes billions of web pages to discover new backlinks, track lost links, and update domain authority scores. The freshness of data depends on when our crawler last visited the referring pages.